SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 267 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $38,000 | -55.8% | 1,600 | -38.5% | 0.01% | -56.0% |
| Q2 2019 | $86,000 | -85.9% | 2,600 | -85.4% | 0.02% | -69.5% |
| Q1 2019 | $612,000 | +119.4% | 17,842 | +107.0% | 0.08% | -8.9% |
| Q4 2018 | $279,000 | -22.5% | 8,621 | +19.7% | 0.09% | +32.4% |
| Q3 2018 | $360,000 | +76.5% | 7,201 | +106.2% | 0.07% | +47.8% |
| Q2 2018 | $204,000 | +51.1% | 3,493 | +2.7% | 0.05% | +48.4% |
| Q4 2017 | $135,000 | +2150.0% | 3,400 | +1600.0% | 0.03% | +3000.0% |
| Q1 2017 | $6,000 | -95.2% | 200 | -95.9% | 0.00% | -93.8% |
| Q4 2016 | $124,000 | -65.9% | 4,900 | -72.6% | 0.02% | -68.0% |
| Q2 2016 | $364,000 | -64.6% | 17,891 | -73.5% | 0.05% | -58.0% |
| Q1 2016 | $1,029,000 | +97.9% | 67,491 | +74.4% | 0.12% | +83.1% |
| Q4 2015 | $520,000 | -47.6% | 38,696 | -45.3% | 0.06% | -43.0% |
| Q3 2015 | $992,000 | – | 70,705 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
| HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
| KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
| Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
| Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
| Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
| AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
| Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
| NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |